Working... Menu

A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00327392
Recruitment Status : Completed
First Posted : May 18, 2006
Results First Posted : June 20, 2012
Last Update Posted : June 20, 2012
Information provided by:
Eisai Inc.

Brief Summary:
Very often patients receive medications before a diagnostic, therapeutic, or surgical procedure to help them relax, keep them calm, and to relieve them from pain. This is called procedural sedation. With respect to minimal-to-moderate procedural sedation for minor surgical procedures, a patient is first given a pain-relief medication (analgesic) and then a medication to help him/her relax and keep calm (sedative). AQUAVAN is a chemically modified form of propofol, a commonly-used sedative drug. AQUAVAN acts like a slow release version of propofol, and is being studied to see if it can safely keep patients calm and relaxed during their medical procedure and then allow for rapid and clear-headed recovery.

Condition or disease Intervention/treatment Phase
Procedural Sedation Drug: AQUAVAN® (fospropofol disodium) Injection Phase 2 Phase 3

Detailed Description:
This is a Phase 3 open-label, single-arm study designed to evaluate the safety of AQUAVAN following pretreatment with an analgesic, fentanyl, in patients who are undergoing minor surgical procedures that require minimal-to-moderate sedation. All patients will be placed on supplemental oxygen via nasal cannula and an electrocardiogram monitor, pulse oximeter, and blood pressure monitor will be attached prior to administration of fentanyl. Assessments will be made to evaluate the safety of AQUAVAN in patients undergoing minor surgical procedures.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 123 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: A Phase 3 Open-Label, Single Arm Study to Assess the Safety of AQUAVAN® (Fospropofol Disodium) Injection for Minimal-to-Moderate Sedation in Patients Undergoing Minor Surgical Procedures
Study Start Date : May 2006
Actual Study Completion Date : December 2007

Primary Outcome Measures :
  1. Incidence of Airway Assistance in Patients Undergoing Minor Surgical Procedures [ Time Frame: 2 hours ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

- Number of sites/patients: Approximately 18 sites and 125 patients.

Inclusion Criteria:

  1. Patient must be able to understand, either orally or in writing, and be able to consent and complete the required assessments and procedures.
  2. Patient provides signed/dated Informed Consent and Health Insurance Portability and Accountability Act (HIPAA) of 1996 authorization after receiving a full explanation of the extent and nature of the study.
  3. Patient must be at least 18 years of age and undergoing one of the specified minor surgical procedures at the time of screening.
  4. If female, patient must be surgically sterile, postmenopausal, or not pregnant or lactating and must have been using an acceptable method of birth control for at least 1 month prior to dosing, with a negative urine pregnancy test result at screening and predose.
  5. Patient meets American Society of Anesthesiologists (ASA) Physical Classification System status of P1 to P4.

Exclusion Criteria:

  1. Patient has a history of allergic reaction or hypersensitivity to any anesthetic agent or opioid.
  2. Patient does not meet nils per os (NPO) status per ASA guidelines or institution's guideline.
  3. Patient has a Mallampati Classification Score of 4; or a Mallampati Classification Score of 3 and a thyromental distance <4 cm, or for any other reason has a difficult airway, in the opinion of the Principal Investigator.
  4. Patient has an abnormal, clinically significant 3-lead ECG finding at predosing period.
  5. Patient has participated in an investigational drug study within 1 month prior to study start.
  6. Patient is unwilling to adhere to pre- and postprocedural instructions.
  7. Patient for whom the use of fentanyl citrate injection (fentanyl) is contraindicated.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00327392

Layout table for location information
United States, Arizona
Precision Trials
Phoenix, Arizona, United States, 85032
United States, Florida
Borland-Groover Clinic
Jacksonville, Florida, United States, 32256
United States, Kentucky
University of Louisville
Louisville, Kentucky, United States, 40202
United States, Louisiana
Medical Research Institute, Inc.
Slidell, Louisiana, United States, 70458
Medical Research Institute
Slidell, Louisiana, United States, 70458
United States, Maryland
Chevy Chase Clinical Research
Chevy Chase, Maryland, United States, 20815
Chesapeake Research Group, LLC
Pasadena, Maryland, United States, 21122
United States, Missouri
St. Louis Women's Healthcare Group
Chesterfield, Missouri, United States, 63017
United States, Montana
International Heart Institute of Montana
Missoula, Montana, United States, 59802
United States, New York
Hudson Valley Urology, PC
Poughkeepsie, New York, United States, 12601
United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27710
United States, South Carolina
Southern Orthopaedic Sports Medicine
Columbia, South Carolina, United States, 29204
Carolina Urologic Research
Myrtle Beach, South Carolina, United States, 29572
United States, Texas
Dallas VA Medical Center
Dallas, Texas, United States, 75216
United States, Utah
Physicians' Research Options
Sandy, Utah, United States, 84070
Sponsors and Collaborators
Eisai Inc.
Layout table for investigator information
Study Director: James B Jones, MD, PharmD Eisai Inc.

Layout table for additonal information Identifier: NCT00327392     History of Changes
Other Study ID Numbers: 3000-0523
First Posted: May 18, 2006    Key Record Dates
Results First Posted: June 20, 2012
Last Update Posted: June 20, 2012
Last Verified: May 2012

Keywords provided by Eisai Inc.:
AV Shunt
Dilatation and Curettage
Rotator Cuff/ Shoulder
Transesophageal Echocardiography

Additional relevant MeSH terms:
Layout table for MeSH terms
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Intravenous
Anesthetics, General